Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. Analysts have a positive outlook on ABT stock.

Abbott stock jumped early Thursday on better-than-expected second-quarter metrics. The company also raised its profit view.

Abbott Laboratories (ABT) is currently at $99.59, up $10.32 or 11.56%